Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis-Reference-Cited by-同舟云学术

Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis

Published:2016-05-17 Issue:5 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gallardo Carmen R¹,Rigau Comas David²,Valderrama Rodríguez Angélica³,Roqué i Figuls Marta⁴,Parker Lucy Anne⁵,Caylà Joan⁶,Bonfill Cosp Xavier⁷

Affiliation:

1. Hospital Universitario San Juan de Alicante; Preventive Medicine and Healthcare Quality Service; Ctra. Nacional. 332 Alicante-Valencia, s/n Alicante Alicante Spain 03550

2. Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 167 Barcelona Catalonia Spain 08025

3. Hospital Universitari Germans Trias i Pujol. Universitat Autònoma de Barcelona; Clinical of Pharmacology Department; Barcelona Spain

4. CIBER Epidemiología y Salud Pública (CIBERESP); Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret 171 Edifici Casa de Convalescència Barcelona Catalunya Spain 08041

5. Universidad Miguel Hernández de Elche, CIBER Epidemiología y Salud Pública (CIBERESP); Department of Public Health, History of Science and Gynaecology; Alicante Spain

6. Agència de Salut Pública de Barcelona, Biomedical Research Institute Sant Pau (IIB Sant Pau), CIBER Epidemiología y Salud Pública (CIBERESP); Barcelona Spain

7. CIBER Epidemiología y Salud Pública (CIBERESP) - Universitat Autònoma de Barcelona; Iberoamerican Cochrane Centre - Biomedical Research Institute Sant Pau (IIB Sant Pau); Sant Antoni Maria Claret, 167 Pavilion 18 (D-13) Barcelona Catalunya Spain 08025

Publisher

Wiley

Subject

Pharmacology (medical)

Reference69 articles.

1. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis;Bartacek;International Journal of Tuberculosis and Lung Disease,2009

2. A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment;Agounitestane;Revue des Maladies Respiratoires,1990

3. Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis;Bellabas;Revue des Maladies Respiratoires,1989

4. Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis;Chaulet;Tuberculosis and Lung Disease,1995

5. United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide;Geiter;Tubercle,1987

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for pulmonary tuberculosis recurrence, relapse and reinfection: a systematic review and meta-analysis;BMJ Open Respiratory Research;2024-03

2. Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features;Pharmaceutics;2024-01-26

3. New drug–drug and drug–nutraceutical salts of anti-emetic drug domperidone: structural and physicochemical aspects of new salts;CrystEngComm;2024

4. From Ideation to Innovation: Integrating Pharmaceutical Innovation and Sustainable Development;World Sustainability Series;2024

5. How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians;Antibiotics;2023-12-14